Tuesday, December 24, 2013

New Trade - $LBMH

My new trade is $LBMHLiberator Medical Supply, Inc. is one of America's fastest growing, leading national providers of direct to consumer medical supplies, with a prime focus on sterile urinary catheters and urological supplies.

Why Buy? -
  
  1. Excellent Results - Click here
  2. Newly Listed on NYSE - More visibility and more transperncy
  3. Key Stats - Click here
  4.  IR Presentation - More information on potential for their markets
  5. Chart - Above 40, 200 DMA and 4 EMA with RSI around 68 - Click here
This is a newly listed stock on NYSE and very few people noticed it until now. I guess there will be articles coming on $LBMH by Seeking Alplha and other analysts. I always love to be ahead of the crowd and hence got some in around $4.17 last night and might add more on a pull back. My PT is $6- $8 with downside risk of $3.75

Other Stocks to watch: $HRT $IMUC $SUPN $HDSN $CAMT $CRMD $RIBT

A general Caution and Advise - As I always advise in my posts, Do not chase stocks. please keep in mind that I am not a Stock Market Analyst or an Investment Adviser to count on my recommendations/alerts. Do your due dilligence  before investing or speculating. Start with a small position, always keep your stop losses in place and emotions out. If you are profiting from a trade then always ring the register. Finally thank me for your profits but do not blame me for your losses because you are the one who pulled the trigger!!!

Friday, December 20, 2013

Re-entered $HRT at 3.45

Insider bought 10K shares recently click here. Low float..has history of ripping higher on news...

A general Caution and Advise - As I always advise in my posts, Do not chase stocks. please keep in mind that I am not a Stock Market Analyst or an Investment Adviser to count on my recommendations/alerts. Do your due dilligence  before investing or speculating. Start with a small position, always keep your stop losses in place and emotions out. If you are profiting from a trade then always ring the register. Finally thank me for your profits but do not blame me for your losses because you are the one who pulled the trigger!!!

Wednesday, December 18, 2013

New Watchlist - $DRAM Going To Double - Congrats on $MEIL - Long $WPCS

Hey Guys,  Congrats if you are long MEIL, our incredible pick on 12/10, click here. We alerted when it was at $2.38 and it hit $5.50 today!!! Also Congrats if you are long $PTIX which we alerted around $1.89 and at several prices in the last few months...couple days back the company was bought by Sonus Networks for $3.75 !!! There were many other winning picks recently and stay tuned for more to come...

Here is our new pick for coming sessions.....

Dataram Corporation (DRAM) - an independent memory manufacturer, develops, manufactures, and markets large capacity memory products primarily used in high performance network servers and workstations worldwide. It provides customized memory solutions for original equipment manufacturers (OEMs) and compatible memory for various brands, including Dell, HP, IBM, and Sun Microsystems.

Why Buy?

Partnership with AMD! -AMD and Dataram have worked together to significantly enhance the dynamic background load-and-save feature in order to create a seamless, non-volatile RAMDisk experience,” said Jason Caulkins, CTO, Dataram. “This underscores AMD and Dataram’s continued dedication to delivering the highest-performing memory products for PC enthusiasts.” Click here for more

2nd Quarter Financial Results: Dataram Continues to Trim Losses as It Reports Fiscal 2014 Second Quarter Financial Results. This is about the future that the company is promising its shareholders. At the current rate of cost reduction and sales expansion I think the stock has potential to double in 2014. Here is what John H. Freeman, Dataram’s president and CEO had to say about 2nd Quarter, “The Company continues to execute its plan of cost reduction and sales expansion. The six percent sales increase over the same quarter of last year and slight increase over the previous quarter of this year is a result of our product expansion, increased sales of Advanced Micro Devices ('AMD') Radeon Memory products and growth in our AMD relationship. We continue to work to expand the number of outlets for our AMD Radeon branded consumer and server memory in addition to exposing more gamers to our AMD Radeon RAMDisk.

Float: Here is the fun part !!! 1.4 million shares in float and that's one of the major forces for the stock to rip higher when the momentum begins.

Besides above factors chart is also looking good with above 50, 200 DMA and 4 EMA, RSI at 58 (not overbought) levels...

Bottomline - Taking CEO comments, future growth, sales expansion, and last but not least the tiny FLOAT into consideration I think DRAM has potential to more double in 2014 !!! I am long.

Other potential play for today is WPCS -  There was whole lot of drama with this stock after hours after it announced that they aquired a start up Bitcoin Trading Software company based in NY. Stock rallied from 3.20 to $5+ after hours and gave back all the profits and ended in red. People were suspecting that the drop was due to sell off fearing a dilution but 8K states "To acquire BTX, the Company entered into a securities purchase agreement (the Purchase Agreement) with certain investors in which WPCS sold 2,348 shares of a newly designated Series E Preferred Stock (the Preferred Stock) and warrants to purchase up to 1,500,000 shares of its common stock (the Warrants), for 100% of the membership interests of BTX. Each share of Preferred Stock has a stated value of $1,000 and is convertible into shares of the Company's common stock equal to the stated value (and all accrued but unpaid dividends) divided by the conversion price of $3.50 per share. The Preferred Stock accrues dividends at a rate of 12% per annum, payable quarterly in arrears. The Warrants have an exercise price of $5.00 per share. "

So if the management releases a PR and clarify that there is no dilution upon this acquisition then stock will rip higher....I am expecting it to hit $5+ IF IF IF there is no dilution...if there is...then we will see...

That's it for now guys...

Happy Trading!

A general Caution and Advise - As I always advise in my posts, Do not chase stocks. please keep in mind that I am not a Stock Market Analyst or an Investment Adviser to count on my recommendations/alerts. Do your due dilligence  before investing or speculating. Start with a small position, always keep your stop losses in place and emotions out. If you are profiting from a trade then always ring the register. Finally thank me for your profits but do not blame me for your losses because you are the one who pulled the trigger!!! 

Friday, December 13, 2013

New Watchlist - $KFX $MATR $INFU $DSKX $CRDS $DLHC $MEIL $CRMD $CRDS $GNVC $CNDO

Congrats to those who made money on MEIL which was alerted at 2.50 and hit $3.35 the same day...close to 25% return...and CRDS alerted at $1.90 and it hit $2.66 the next day...40% return and HRT from 3.95 to 4.79 the same day as predicted in my previous newsletter !!!

Here are my new and some old picks on my watchlist.

KFX - This is my favorite trader @super_trades pick :) Kofax Capture provides industry-leading scan-to-archive capabilities by scanning documents and forms to create digital images, extracting index data for retrieval purposes and delivering the images and associated data to a variety of repositories and applications.

KFX just  IPO'd 2,000,000 shares of common stock at a price to the public of $5.85 per share and started trading on Nasdaq since 12/05. We don't know how low the float is so there are high chances of stock ripping higher upon a positive PR and once active traders notice it. I am long.

MATR - Mattersight’s "big data" analytics are based on millions of proprietary algorithms and the application of unique behavioral models. The company's SaaS+ delivery model combines analytics in the cloud with deep customer partnerships to drive significant business value...

Why Buy - Big Data is hot and MATR is getting noticed by big guys. Today Goldman Capital Management revealed upping its stake to 6.3%, click here for the news. Float is 8M shares and the chart looks good (above its 50, 200 dma and 4ema, RSI at 52 so not overbought. I am long.
Pivot Points -
Pivot Point 4.63, Res1 4.77, Res2 4.88, Res3 5.02 - Sup1 4.52, Sup2 4.38, Sup3 4.27
My Price Target is $6-$8 - SA Article Mattersight Is Ready To Be The Next Big Data Darling - Click here

INFU - InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related services in the United States and Canada

Why Buy - INFU is trading at 52 week high and poised for a huge breakout. I like their key stats, click here and the chart looks strong...above 50, 200 dma, and 4 ema with RSI 74. Also couple SA articles  has more details. I would suggest reading them. I am long and might add on a pullback.
Pivot Points -
Pivot Point 2.11, Res1 2.21, Res2 2.27, Res3 2.37- Sup1 2.05, Sup2 1.95, Sup3 1.89
My Price Target is $4-$5 SA article InfuSystem: MBO Off, But Value Remains - Click here

CRDS - 4Q results were out this evening and they are as per expectations. Click here for results and here for the CC Transcript. It's all about the future growth. Price Targets remain the same as mentioned in my previous blog.

DLHC - Volume and price breakout. Low float stock..could hit $2+ if the same momo continues. No position. Downside risk 1.35 and Upside Potential is $3.50-$3

DSKX - Nice price action and chart setup...Could hit $3.50 if the same momo continues. Downside risk 1.90 - 2 and Upside Potential is $3.50 - $4. I am long and might add on a pullback

MEIL - High chances of crossing $3 and consolidating between 3 and 3.50 before the next leg up. The recent acquisition is the key. Another low float crack stock that has potential to surprise !!! I am long at 2.40 and took some off around 3.25 and other prices...but might if it goes back to initial entry price.

CRMD - News about its first sales of Neutrolin in the EU moved the stock. I got in at .84 and sold majority at .89 and some at .81..on watch

GNVC - Stock ripped higher after the National Institutes of Health's Recombinant DNA Advisory Committee (RAC) unanimously approved the protocol for initiation of a Phase 1 study of CGF166, an adenoviral vector engineered to express the human atonal gene, in patients with severe hearing loss. ON WATCH as volume and price action suggests to take the trade on a pull back...this will be a swing trade.

CNDO - After hours news about its Potential Benefits of TSO Immunotherapy in First 5 Patients ripped the stock higher. I got in at 1.85 or so and 3/4th of my position between 2.04 and 2.25. I might re-enter depending on the trend...this is a stock worth adding to your watchlist..

That's it for now guys...Have a great trading day !!!

A general Caution and Advise - As I always advise in my posts, Do not chase stocks. please keep in mind that I am not a Stock Market Analyst or an Investment Adviser to count on my recommendations/alerts. As always please do your DD before investing or speculating, start with a small position, always keep your stop losses in place and emotions out. If you are profiting from a trade then always ring the register. Finally thank me for your profits but do not blame me for your losses because you are the one who pulled the trigger!!!

Tuesday, December 10, 2013

2 Stocks to jump at least 25 - 30% before Christmas !!! $MEIL and $HRT

Congrats to those who got in $CRDS at 1.90 on my alert yesterday! You would have made 25% if you bought it in the pre-market and sold it during regular hours at $2.40!!!

Here are my new picks...

Pick # 1 - MEIL - Methes Energies International Ltd., through its subsidiaries, designs and installs biodiesel processing systems under the Denami 600 and Denami 3000 brands. It also produces and distributes biodiesel in North America. Methes Energies is developing cutting-edge biodiesel processors, pre-treatment systems, as well as other solutions that address real and specific biodiesel production challenges. While the North American demand for biodiesel is sizeable, we are positioned for a global expansion with a focus on Europe, South America, Africa and Asia, where the need for biodiesel is increasing. At Methes Energies, our focus is to become the leading developer, marketer, manufacturer and service provider of compact continuous flow biodiesel processors, processor systems, training, maintenance and related biodiesel services.

Click here to view their facility 

 Why Buy Now? 

Global Demand: The global biofuels market is currently valued at around $90 billion. [2] High crude oil prices, government mandates on the use of biofuels due to increased focus on reducing carbon emissions as well as improving energy security, and technology advancements driving cost reductions are some of the key factors driving the rapid growth in the biofuels market..click here for more information on demand for Biodiesel markets.

MEIL is a thinly traded small cap stock with 4.9 million shares in float. It's 3 month average volume is 6,800 shares but today it traded about 15 times of its average volume on the news that it signed Letter of Intent to acquire the assets of OTC Energy Technologies Inc. Click here

Here is what both CEOs had to say about this transaction

John Loewen, Vice President of Operations at Methes Energies said, "We are first and foremost a technology company, and we are proud to be adding to our portfolio this way. We are excited about the opportunity to offer a smaller solution to people that don't have the $100's of millions typically associated which such projects. What we've seen at their small scale facility is truly amazing, and our goal is to quickly package and deploy turn-key solutions similar to our biodiesel processors. We look forward to the completion of this transaction which we expect will bring substantial revenues and in turn create significant value for our shareholders."

Paul Goodrow, President of OTC Energy Technologies Inc. continued, "What attracted us to Methes was their proven ability to turn innovative process designs into working, efficient production plants. We believe that the OTC technology has the potential to be a low cost producer of renewable and alternative fuels. And we believe that smaller, modular plants and low costs are not mutually exclusive. We anticipate that our hydrocarbon fuels will be cost competitive with, and will prove to be an acceptable replacement for crude oil derived transportation fuels. We look forward to working with Methes to rollout what we think will be a game changing business model."

This news was overlooked by many players today and as usual I got lucky to get in the trade ahead of the crowd. Stock was sold out for various reasons in the past and it formed a nice base between $2.50 and $3 in the last couple months. It tried to breach $3 level today but failed. I think once it gets more
exposed to trader community it will not stay at these levels for long. Today's news is a game changer for MEIL and I think it has potential to hit $6 -$7 next year (post acquisition) and in short term it has potential to hit $3.50 - $4.

Read Wall Street CheatSheet article about MEIL

I am long MEIL around 2.40 and might accumulate more if it drops.

Pick # 2 - HRT: Arrhythmia Research Technology Inc engages in the development and distribution of signal-averaged electrocardiographic software under the Predictor brand name. Its Predictor software is used in research and clinical environments to diagnose the risk of certain heart arrhythmias.

 For more information please check their websites:
http://www.arthrt.com
http://www.micronproducts.com (subsidiary of HRT)


This is another thinly traded small cap stock with 2.1 million shares in float. It has been on my watch for long time and I traded it between 2.50 and 3.50 at several points where it hit 52 week high. It just touched its 52 week high on relatively high volume compared to its 3 month average volume and has very high chances of breaking out here and hitting $5 in short period.

HRT 3rd Quarter results were so-so but the upbeat in CEO confidence is what attracted me more towards this stock.

Salvatore Emma, Jr., the Company's President and CEO, commented, "The Company has a significant opportunity for revenue growth from sales of orthopedic implant components. Shipments of these components increased dramatically in the third quarter, and further increases are expected in the fourth quarter and into 2014. The Company will continue to dedicate its financial resources to increase its production capabilities while targeting new leads in this multi-billion dollar market. The market for orthopedic implants is growing rapidly worldwide and the company has unique expertise in quick-turn patient specific implant components. 

"During the third quarter, the Company also realized increases in its custom injection molding business. These increases are due to strong demand in medical, defense, and automotive markets. Plastic injection molded products sales have increased with the launch of new customer programs in the second half of the year. The Company also expects to see growth in the fourth quarter of 2013 and into 2014. The company has also started to manufacture and ship components used by law enforcement and military which hold excellent potential for growth in the less-than-lethal ammunition market.

"The Company is working on opportunities to regain market share in sensor products. Significant improvements in process, quality, service, and product performance have started to yield positive results. Increases in sensor volume are expected in the fourth quarter and into 2014 due to a steady increase in global demand as well as new programs with existing customers. The Company will continue its investments in research and development of new sensor technology."

I am long HRT with PT of $5- $6 very soon and $8 - $10 next year!

 A general Caution and Advise - As I always advise in my posts, Do not chase stocks. please keep in mind that I am not a Stock Market Analyst or an Investment Adviser to count on my recommendations/alerts. As always please do your DD before investing or speculating, start with a small position, always keep your stop losses in place and emotions out. If you are profiting from a trade then always ring the register. Finally thank me for your profits but do not blame me for your losses because you are the one who pulled the trigger!!!

Monday, December 9, 2013

$CRDS - A Potential Multibagger - Others $BLIN, $CHYR, $DYNT, $ETAK, $INFU, $OPTT, $PTIX, $RITTW, $TRIT, $VIDE, $VSCI, $WPCS

CRDS - Crossroads Systems, Inc. provides data protection solutions and services worldwide. It develops and markets products that offer online access to data archives through tape-based archive storage solutions for businesses. They have 5 core assets, those are: their newest product, StrongBox, OEM products: SPHiNX and RVA; our net operating losses; our '972 patent portfolio; and 108 other patents referred to as non-'972 patent portfolio.

Market Potential: According to management comments in 3Q CC, StrongBox solves real and increasing pain for a multibillion-dollar market. Their early successes in different market segments have validated customer demand and provided valuable customer feedback. Based on positive market response, the adoption of StrongBox into their partners' core solution sets and their unique product positioning, Management believes the industry is beginning to acknowledge their value proposition.

They have impressive wins and repeat business from customers, such as Jet Propulsion Labs, industry leaders like Hitachi Data Systems, Fujifilm, ViON, Mainline and Iron Mountain have all recognized our market opportunity.

Little background on their 3rd Quarter: For the third quarter, revenue totaled $2.8 million. This represents a decrease of 21% or $700,000 from the same quarter a year ago. The decrease is attributable to a one-time deal with a large RVA customer in 2012, and declines in Iron Mountain custom development revenue. Gross margin percentages remain consistent year-over-year at 75%. cash balance of $9.9 million, compared to $6 million at the end of Q2. They received a net amount of $7 million in July from our Fortress financing after subtracting expenses and repaying our debt to Silicon Valley Bank.

CRDS saw some positive trends in the third quarter. Revenue from StrongBox unit sales and strategic partners was up, although modestly. Expenses were down quarter-over-quarter and we instituted significant cost controls that should lead to a further 25% reduction in operating expenses in fiscal 2014. So they are trying to improve their top lines through sales and strategic partners and bottom line by significant cost control.

Why Buy Now? Crossroads can be multifaceted play 1. Big Data 2. Patent Infringement 3. Network Storage (LTFS)

Big Data: The Crossroads StrongBox® addresses these concerns with an integrated, intelligent Big Data solution that combines StrongBox with $IBM tape libraries and tape drives which support the open standard Linear Tape File System (LTFS). Click here to read more about its potential

Patent Infringement: Crossroads Systems Files Patent Infringement Suits against all big names like Oracle, Tandberg, Dell, and Huawei. Speculators LOVE IP plays, SPEX, VRNG, DSS, VHC etc...Click here for their PI info

Technicals: $CRDS built a strong base between $1.50 and $1.80 and with earnings on 12/12 it could lead to a HUGE breakout even if there is any news about their new IP cases or improved financials.

Insider Buying: There has been a HUGE buying by insiders recently. Click here

Net Operating Losses (NOL): Crossroads has accumulated a $116 million NOL, or net operating loss, which can be used to offset taxes on our future profits.

Huge headcount reduction as part of cost control

Positive Comments form the CEO in 3rd Quarter Conference Call: We will be carefully managing expenses in order to sustain a cost structure that gives us as much time as possible to implement our plans and we're reviewing our IP strategy and should have some news to share in the next 45 days. We strongly believe that patient investors will be amply rewarded.

Other stocks on watch: $PLUG $BLDP $UQM (Fuel Cell/EV stocks..ripped higher and are due for a pull back..$XRSC back on watch list at these levels. I might initiate a position when the price is appropriate. I am long $BLIN, $CHYR, $DYNT, $ETAK, $INFU, $OPTT, $PTIX, $RITTW, $TRIT, $VIDE, $VSCI, $WPCS and a bunch of OPTIONS !!!

Bottomline: After reading into the 3rd quarter report and the tone of the management, I think there is a huge room for CRDS to move higher. From a tech standpoint Chart looks bullish and I think it should hit $2.25 to $2.40 before earnings and have a fresh breakout upon earnings if there are no unpleasant surprises (which I am not expecting).

Disclosure: Added more at 1.90 on Friday to my existing position and my average is around $1.50. My initial alert is at $1.08 on Twitter and it hit $2.08 and then pulled back, consolidated and is poised for new breakouts...

A general Caution and Advise - As I always advise in my posts, Do not chase stocks. please keep in mind that I am not a Stock Market Analyst or an Investment Adviser to count on my recommendations/alerts. As always please do your DD before investing or speculating, start with a small position, always keep your stop losses in place and emotions out. If you are profiting from a trade then always ring the register. Finally thank me for your profits but do not blame me for your losses because you are the one who pulled the trigger!!!

Who is Mr.Incredible?

My photo
New Jersey, United States
Mr.Incredible is a Momentum/Technical Breakout player who trades small/micro cap plays and who saw a 600% Growth since 2006, Yes even in this down market. I am going to post my real trades (including profits/losses) soon...As a general caution and advice Please start with a small position and always keep your stop losses in place just in case....As usual Do your DD before investing. Thank me for your profits and don't blame me for your losses because you are the one who pulled the trigger!!!